Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03200587
Title Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Utah
Indications

renal cell carcinoma

Therapies

Avelumab + Cabozantinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.